| Autor: |
Dermitzaki N; Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece., Baltogianni M; Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece., Tsekoura E; Paediatric Department, Asklepieion Voula's General Hospital, 16673 Athens, Greece., Giapros V; Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece. |
| Jazyk: |
angličtina |
| Zdroj: |
Pathogens (Basel, Switzerland) [Pathogens] 2024 Aug 06; Vol. 13 (8). Date of Electronic Publication: 2024 Aug 06. |
| DOI: |
10.3390/pathogens13080660 |
| Abstrakt: |
Invasive Candida infections represent a significant cause of morbidity and mortality in neonatal intensive care units (NICUs), with a particular impact on preterm and low-birth-weight neonates. In addition to prematurity, several predisposing factors for Candida colonization and dissemination during NICU hospitalization have been identified, including prolonged exposure to broad-spectrum antibiotics, central venous catheters, parenteral nutrition, corticosteroids, H2 antagonist administration, and poor adherence to infection control measures. According to the literature, the implementation of antifungal prophylaxis, mainly fluconazole, in high-risk populations has proven to be an effective strategy in reducing the incidence of fungal infections. This review aims to provide an overview of risk factors for invasive Candida infections and current perspectives regarding antifungal prophylaxis use. Recognizing and reducing people's exposure to these modifiable risk factors, in conjunction with the administration of antifungal prophylaxis, has been demonstrated to be an effective method for preventing invasive candidiasis in susceptible neonatal populations. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
